155 related articles for article (PubMed ID: 27889608)
21. Downregulation of Lgr6 inhibits proliferation and invasion and increases apoptosis in human colorectal cancer.
Wang F; Dai CQ; Zhang LR; Bing C; Qin J; Liu YF
Int J Mol Med; 2018 Jul; 42(1):625-632. PubMed ID: 29693156
[TBL] [Abstract][Full Text] [Related]
22. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
23. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
24. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
[TBL] [Abstract][Full Text] [Related]
25. Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells.
Huang WS; Huang CY; Hsieh MC; Kuo YH; Tung SY; Shen CH; Hsieh YY; Teng CC; Lee KC; Lee KF; Kuo HC
Cell Physiol Biochem; 2018; 51(6):2616-2630. PubMed ID: 30562740
[TBL] [Abstract][Full Text] [Related]
26. eIf3a mediates malignant biological behaviors in colorectal cancer through the PI3K/AKT signaling pathway.
Huo C; Wu D; Li X; Zhang Y; Hu B; Zhang T; Ren J; Wang T; Liu Y
Cancer Biol Ther; 2024 Dec; 25(1):2355703. PubMed ID: 38782896
[TBL] [Abstract][Full Text] [Related]
27. A Deregulated PI3K-AKT Signaling Pathway in Patients with Colorectal Cancer.
Zhang T; Ma Y; Fang J; Liu C; Chen L
J Gastrointest Cancer; 2019 Mar; 50(1):35-41. PubMed ID: 29110225
[TBL] [Abstract][Full Text] [Related]
28. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
Hu J; Li G; Liu L; Wang Y; Li X; Gong J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
[TBL] [Abstract][Full Text] [Related]
29. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
[TBL] [Abstract][Full Text] [Related]
30. ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.
Wu M; Li R; Qin J; Wang Z; Guo J; Lv F; Wang G; Huang Y
J Mol Histol; 2023 Dec; 54(6):621-631. PubMed ID: 37776473
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells.
Zhang P; Chen Z; Ning K; Jin J; Han X
Biochem Biophys Res Commun; 2017 Aug; 490(3):1132-1138. PubMed ID: 28676400
[TBL] [Abstract][Full Text] [Related]
32. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
33. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
34. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
[TBL] [Abstract][Full Text] [Related]
35. SNORD126 promotes HCC and CRC cell growth by activating the PI3K-AKT pathway through FGFR2.
Fang X; Yang D; Luo H; Wu S; Dong W; Xiao J; Yuan S; Ni A; Zhang KJ; Liu XY; Chu L
J Mol Cell Biol; 2017 Jun; 9(3):243-255. PubMed ID: 27913571
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways.
Liu YD; Ji CB; Li SB; Yan F; Gu QS; Balic JJ; Yu L; Li JK
Int Immunopharmacol; 2018 Jun; 59():375-383. PubMed ID: 29689497
[TBL] [Abstract][Full Text] [Related]
37. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
[TBL] [Abstract][Full Text] [Related]
38. miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway.
Jia L; Luo S; Ren X; Li Y; Hu J; Liu B; Zhao L; Shan Y; Zhou H
Dig Dis Sci; 2017 Dec; 62(12):3447-3459. PubMed ID: 29030743
[TBL] [Abstract][Full Text] [Related]
39. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
[TBL] [Abstract][Full Text] [Related]
40. Thyroid hormone receptor β1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
Zhu L; Tian G; Yang Q; De G; Zhang Z; Wang Y; Nie H; Zhang Y; Yang X; Li J
Oncol Rep; 2016 Sep; 36(3):1419-26. PubMed ID: 27431682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
